10 months ago
NVAX
AnalystsAlec StranahanAlec Stranahan's Stock Forecasts
AnalystsAlec Stranahan
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4669 out of 4861 analysts
Average Return
-32.34%
Win Rate
35%7 out of 20
Risk vs Reward
Poor
Good
Alec Stranahan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Turning Point Therapeutics IncTPTX | +106.89% | $36.74 | $76.01 | 2022-05-19 - 2022-08-16 | Strong Buy |
Revolution Medicines IncRVMD | +55.46% | $28.38 | $44.12 | 2024-01-04 - 2025-01-03 | Strong Buy |
Krystal Biotech IncKRYS | +41.95% | $117.53 | $166.83 | 2023-05-21 - 2024-05-21 | Strong Buy |
Hookipa Pharma IncHOOK | +41.33% | $9.80 | $5.75 | 2022-12-01 - 2023-12-01 | Sell |
Krystal Biotech IncKRYS | +38.71% | $117.39 | $162.83 | 2023-05-24 - 2024-05-24 | Strong Buy |
Alec Stranahan Analyst Color
Get additional color on Alec Stranahan's coverage of popular stocks
a year ago
NVAX
Alec Stranahan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | 1 | Strong Buy | $42.00 | +147.06% | Upgrades | 25 days ago |
Y Mabs Therapeutics IncYMAB | 5 | Hold | $12.00 | +155.86% | Maintains | 2 months ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $15.00 | +228.23% | Initiates Coverage On | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 4 | Strong Buy | $25.00 | +265.50% | Maintains | 3 months ago |
Caribou Biosciences IncCRBU | 1 | Strong Buy | $11.00 | +1,396.60% | Maintains | 3 months ago |
Erasca IncERAS | 2 | Strong Buy | $5.00 | +331.03% | Upgrades | 3 months ago |
Perspective Therapeutics IncCATX | 2 | Hold | $6.00 | +209.28% | Downgrades | 5 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $55.00 | +49.62% | Maintains | 9 months ago |
Novavax IncNVAX | 2 | Hold | $18.00 | +200.00% | Maintains | 10 months ago |
Krystal Biotech IncKRYS | 3 | Strong Buy | $140.00 | N/A | Maintains | 2 years ago |
Xencor IncXNCR | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Tg Therapeutics IncTGTX | 2 | Sell | $6.00 | N/A | Maintains | 2 years ago |
Hookipa Pharma IncHOOK | 1 | Sell | $5.00 | N/A | Downgrades | 2 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Turning Point Therapeutics IncTPTX | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.